Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Testing the MapHabit System with Autistic Young Adults During Life Transitions

Tests the MapHabit System in autistic young adults facing major life changes.

Plain-language title generated from the registry record
Registry title: Evaluating the Feasibility of Collecting User Interaction Data at the Emory Autism Center Using MapHabit Software

Key facts

Where
Atlanta, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 24 years old?

Source: NCT07859306, who can take part

Where in United States

  • The Emory ClinicAtlanta, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Emory University
Trial code
NCT07859306
Record updated
5 October 2026
Original description
The purpose of this study is to evaluate the impact of the MapHabit System on autistic transition-age youth (ages 18-24) as they navigate key life transitions including graduating from high school, entering adult services, pursuing employment or education, and community-based living.Read full original descriptionShow less

Evaluating the Feasibility of Collecting User Interaction Data at the Emory Autism Center Using MapHabit Software

The purpose of this study is to evaluate the impact of the MapHabit System on autistic transition-age youth (ages 18-24) as they navigate key life transitions including graduating from high school, entering adult services, pursuing employment or education, and community-based living.

Inclusion: 18 -24 years old at time of enrollment; Documented diagnosis of Autism, confirmed through prior clinical evaluation and diagnostic reports; Ability to provide informed consent independently or availability of legally authorized representative.

Exclusion: Children; Inability to provide consent or lack of availability of a legally authorized representative; Active crisis requiring intensive intervention.

ClinicalTrials.gov NCT07859306